Litigation News

An independent resource on litigation related to recall of drugs and personal injuries resulting from prescription medication.

Wednesday, November 07, 2007

Trasylol recall


The story with drug companies is always the same. They know that their drugs are dangerous and could even killing the people but lust for profit is so high that they keep pushing the drug as long as they can.

Then they get caught. And that is the point at which Bayer has arrived with regards to anti-bleeding drug Trasylol (aprotinin), which has been linked to a higher risk of death. The drug is used during heart bypass surgery.

For as long as one year a mountain of data had shown risk of death, kidney failure and strokes but only after regulators in several countries forced it, the company has decided to recall it. As expected, the lawsuits by victims will be filed soon.

Labels: , , ,